Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Azelis agrees to acquire S&D Group
However, S&D Group firms, involved in the pharmaceutical finished dosage (S&D Pharma), chemical synthesis and laboratory supply markets (Chemgo) as well as part of its personal care actives
However, S&D Group firms, involved in the pharmaceutical finished dosage (S&D Pharma), chemical synthesis and laboratory supply markets (Chemgo) as well as part of its personal care actives
Sanofi Pasteur’s dengue vaccine candidate, which targets all four virus serotypes, is in Phase 3 clinical study. Sanofi Pasteur dengue vaccine candidate has been evaluated in clinical studies
By using this solution, organizations will be able to deliver on new reform-mandated cost efficiencies, and simultaneously provide superior customer service consistently across all communication channels. Pegasystems enables
Centricity Practice Solution 10 is the evolved, fully integrated EMR and practice management system for physician practices, GE Healthcare said. It has already attained 2011/2012 Meaningful Use Stage
The HCR virtualizes image and non-image data to create a metadata repository based on any information system (independent of source applications), and gives healthcare providers a consolidated view
The formula has been created to maximise the potency and absorption of natural ingredients by using a unique 6-step proprietary blending and extraction process. The key ingredients of
Antula is established in the Nordics with its own organization. The acquisition of Antula offers Meda clear growth opportunities, partly through Meda and Antula’s existing prescription-free (OTC) products,
Patients with congenital Factor XIII do not make enough Factor XIII, a substance in the blood that is important for normal clotting, and people with this condition are
Simponi (golimumab) is a TNF-alpha blocker. Simponi, typically injected monthly alone or in combination with methotrexate, was approved by the FDA on 24 April 2009 for the treatment
Apart from eyeing OTC brands across vitamins, mineral supplements, orthopaedic, gynaecology and nutraceutical brands, Sanofi Aventis is also looking for brands in anti-infective, antibiotics, respiratory tract infection and